Matches in SemOpenAlex for { <https://semopenalex.org/work/W2748455576> ?p ?o ?g. }
- W2748455576 abstract "Seizure is a common complication for severe traumatic brain injury (TBI). Valproic acid (VPA) is a first-line antiepileptic drug, though its metabolism is affected by genetic polymorphisms and varies between individuals. The aim of this study was to investigate such association and to explore its influence on the occurrence of early post-traumatic seizure. A prospective case control study was conducted from 2012 to 2016 recruiting adult patients with severe TBI. Electroencephalograph (EEG) monitoring was performed approximately 4 h for each patient from day 1 to day 7 after injury. If seizures were detected, EEG monitoring was extended until 12 h after seizures being controlled. Genetic polymorphisms in UGT1A6, UGT2B7, CYP2C9, and CYP2C19 were analyzed in association with daily VPA plasma concentrations, adjusted dosages, and occurrence of seizures. Among the 395 recruited patients, eighty-three (21%) had early post-traumatic seizure, of which 30 (36.14%) were non-convulsive. Most seizures were first detected on day 1 (34.94%) and day 2 (46.99%) after injury. Patients with seizure had longer ICU length of stay and relatively lower VPA plasma concentrations. Patients with UGT1A6_19T > G/541A > G/552A > C double heterozygosities or CYP2C9 extensive metabolizers (EMs) initially had lower adjusted VPA plasma concentrations (power >0.99) and accordingly require higher VPA dosages during later time of treatment (power >0.99). The odds ratio indicated a higher risk of early post-traumatic seizure occurrence in male patients (OR 1.96, 95% CI 1.01-3.81, p = 0.043), age over 65 (OR 2.13, 95% CI 1.01-4.48), and with UGT1A6_19T > G/541A > G/552A > C double heterozygosities (OR 2.38, 95% CI 1.11-5.10, p = 0.02), though the power of the difference was between 0.54 to 0.61. Due to limited facility, the actual frequency of non-convulsive seizures is suspected to be higher than identified. There has been discrepancy regarding to genetic polymorphisms and VPA metab olism between this study and some previous reports. This could be related to confounders such as sample size, race, and patient age. Another limitation is that the case numbers of certain genotypes are limited in this study. Continuous EEG monitoring is necessary to detect both convulsive and non-convulsive early post-traumatic seizures in severe TBI patients. UGT1A6/CYP2C9 polymorphisms have influence on VPA metabolism. UGT1A6_19T > G/541A > G/552A > C double heterozygositie is associated with occurrence of early post-traumatic seizures in addition to patients’ age and gender. Further investigations with larger sample size are required to confirm the difference. Retrospectively registered with Chinese Clinical Trail Registry on 1st Jan 2016 ( ChiCTR-OPC-16007687 )" @default.
- W2748455576 created "2017-08-31" @default.
- W2748455576 creator A5005164003 @default.
- W2748455576 creator A5018558120 @default.
- W2748455576 creator A5021806277 @default.
- W2748455576 creator A5054871862 @default.
- W2748455576 creator A5081785928 @default.
- W2748455576 creator A5082594566 @default.
- W2748455576 date "2017-08-25" @default.
- W2748455576 modified "2023-10-10" @default.
- W2748455576 title "Early post-traumatic seizures are associated with valproic acid plasma concentrations and UGT1A6/CYP2C9 genetic polymorphisms in patients with severe traumatic brain injury" @default.
- W2748455576 cites W1687619523 @default.
- W2748455576 cites W1807962052 @default.
- W2748455576 cites W1923734449 @default.
- W2748455576 cites W1969672346 @default.
- W2748455576 cites W1971698086 @default.
- W2748455576 cites W1975508166 @default.
- W2748455576 cites W1982677579 @default.
- W2748455576 cites W1982734495 @default.
- W2748455576 cites W1984111881 @default.
- W2748455576 cites W1988684735 @default.
- W2748455576 cites W2011320585 @default.
- W2748455576 cites W2024996811 @default.
- W2748455576 cites W2025911636 @default.
- W2748455576 cites W2030655611 @default.
- W2748455576 cites W2032001205 @default.
- W2748455576 cites W2035079958 @default.
- W2748455576 cites W2042731951 @default.
- W2748455576 cites W2046113992 @default.
- W2748455576 cites W2050086797 @default.
- W2748455576 cites W2053863013 @default.
- W2748455576 cites W2054258745 @default.
- W2748455576 cites W2067774950 @default.
- W2748455576 cites W2070605227 @default.
- W2748455576 cites W2079835121 @default.
- W2748455576 cites W2080983407 @default.
- W2748455576 cites W2082136405 @default.
- W2748455576 cites W2092021916 @default.
- W2748455576 cites W2113615687 @default.
- W2748455576 cites W2117039119 @default.
- W2748455576 cites W2120869603 @default.
- W2748455576 cites W2128524303 @default.
- W2748455576 cites W2143578889 @default.
- W2748455576 cites W2158139359 @default.
- W2748455576 cites W2163476723 @default.
- W2748455576 cites W2164261965 @default.
- W2748455576 cites W2205252735 @default.
- W2748455576 cites W2272686432 @default.
- W2748455576 cites W2316055407 @default.
- W2748455576 cites W2335572236 @default.
- W2748455576 cites W2399856487 @default.
- W2748455576 cites W2402297723 @default.
- W2748455576 cites W4244691908 @default.
- W2748455576 doi "https://doi.org/10.1186/s13049-017-0382-0" @default.
- W2748455576 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5574127" @default.
- W2748455576 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/28841884" @default.
- W2748455576 hasPublicationYear "2017" @default.
- W2748455576 type Work @default.
- W2748455576 sameAs 2748455576 @default.
- W2748455576 citedByCount "16" @default.
- W2748455576 countsByYear W27484555762017 @default.
- W2748455576 countsByYear W27484555762019 @default.
- W2748455576 countsByYear W27484555762020 @default.
- W2748455576 countsByYear W27484555762021 @default.
- W2748455576 countsByYear W27484555762022 @default.
- W2748455576 countsByYear W27484555762023 @default.
- W2748455576 crossrefType "journal-article" @default.
- W2748455576 hasAuthorship W2748455576A5005164003 @default.
- W2748455576 hasAuthorship W2748455576A5018558120 @default.
- W2748455576 hasAuthorship W2748455576A5021806277 @default.
- W2748455576 hasAuthorship W2748455576A5054871862 @default.
- W2748455576 hasAuthorship W2748455576A5081785928 @default.
- W2748455576 hasAuthorship W2748455576A5082594566 @default.
- W2748455576 hasBestOaLocation W27484555761 @default.
- W2748455576 hasConcept C118552586 @default.
- W2748455576 hasConcept C126322002 @default.
- W2748455576 hasConcept C156957248 @default.
- W2748455576 hasConcept C162156334 @default.
- W2748455576 hasConcept C2777172819 @default.
- W2748455576 hasConcept C2778186239 @default.
- W2748455576 hasConcept C2779253243 @default.
- W2748455576 hasConcept C2781017439 @default.
- W2748455576 hasConcept C3946865 @default.
- W2748455576 hasConcept C42219234 @default.
- W2748455576 hasConcept C526171541 @default.
- W2748455576 hasConcept C62231903 @default.
- W2748455576 hasConcept C71924100 @default.
- W2748455576 hasConceptScore W2748455576C118552586 @default.
- W2748455576 hasConceptScore W2748455576C126322002 @default.
- W2748455576 hasConceptScore W2748455576C156957248 @default.
- W2748455576 hasConceptScore W2748455576C162156334 @default.
- W2748455576 hasConceptScore W2748455576C2777172819 @default.
- W2748455576 hasConceptScore W2748455576C2778186239 @default.
- W2748455576 hasConceptScore W2748455576C2779253243 @default.
- W2748455576 hasConceptScore W2748455576C2781017439 @default.
- W2748455576 hasConceptScore W2748455576C3946865 @default.
- W2748455576 hasConceptScore W2748455576C42219234 @default.
- W2748455576 hasConceptScore W2748455576C526171541 @default.
- W2748455576 hasConceptScore W2748455576C62231903 @default.
- W2748455576 hasConceptScore W2748455576C71924100 @default.